Detalles de la búsqueda
1.
Network approach in liquidomics landscape.
J Exp Clin Cancer Res;
42(1): 193, 2023 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37542343
2.
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis.
J Bone Oncol;
37: 100459, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36338920
3.
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial.
Front Oncol;
12: 925366, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36185306
4.
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
J Hematol Oncol;
15(1): 9, 2022 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35062993
5.
Long-term response to crizotinib in a 17-year-old boy with treatment-naïve ALK-positive non-small-cell lung cancer.
Cancer Rep (Hoboken);
5(3): e1483, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092185
6.
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Support Care Cancer;
30(3): 2455-2465, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779921
7.
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Front Oncol;
11: 712053, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778029
8.
Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.
Clin Colorectal Cancer;
20(4): 318-325, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34380594
9.
Letter to the Editor Regarding "18F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports".
World Neurosurg;
150: 253-254, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098659
10.
Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience.
Anticancer Res;
41(5): 2553-2561, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33952483
11.
Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
Case Rep Oncol;
14(1): 634-640, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33976646
12.
Assessment of Resistance Mechanisms and Clinical Implications in Patients with KRAS Mutated-Metastatic Breast Cancer and Resistance to CDK4/6 Inhibitors.
Cancers (Basel);
13(8)2021 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33923563
13.
Concomitant Mutations G12D and G13D on the Exon 2 of the KRAS Gene: Two Cases of Women with Colon Adenocarcinoma.
Diagnostics (Basel);
11(4)2021 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33917572
14.
Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review.
J Oncol Pharm Pract;
27(6): 1542-1547, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541207
15.
Prognostic Value of 18F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223.
Biomedicines;
8(12)2020 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33266047
16.
PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer.
Int J Mol Sci;
21(18)2020 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32962309
17.
Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
Nucl Med Commun;
41(10): 1089-1094, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32732599
18.
Targeting Epidermal Growth Factor Receptor (EGFR) in Pediatric Colorectal Cancer.
Cancers (Basel);
12(2)2020 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32053874
19.
BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors.
BMC Cancer;
20(1): 129, 2020 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32066410
20.
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens.
Commun Biol;
3(1): 85, 2020 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32099064